Topical Application with a New NF-κB Inhibitor Improves Atopic Dermatitis in NC/NgaTnd Mice
Open Access
- 1 April 2007
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 127 (4), 855-863
- https://doi.org/10.1038/sj.jid.5700603
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A New IκB Kinase β Inhibitor Prevents Human Breast Cancer Progression through Negative Regulation of Cell Cycle TransitionCancer Research, 2006
- A novel IKKβ inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistanceBiochemical and Biophysical Research Communications, 2004
- Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injuryCardiovascular Research, 2004
- Role of Substance P in an NC/Nga Mouse Model of Atopic Dermatitis-Like DiseaseInternational Archives of Allergy and Immunology, 2004
- IgE crosslinkage of Fcε receptor I induces both production and activation of matrix metalloproteinase-9 in mast cellsCellular Immunology, 2004
- Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized studyClinical and Experimental Allergy, 2004
- Aggregation of the High-Affinity IgE Receptor FcεRI on Human Monocytes and Dendritic Cells Induces NF-κB ActivationJournal of Investigative Dermatology, 2002
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Treatment of atopic dermatitis: Role of tacrolimus ointment as a topical noncorticosteroidal therapyJournal of Allergy and Clinical Immunology, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998